Pfizer acquires rights to Protalix’s Gaucher drug – Reuters

Posted by admin | Stock Exchange US | Tuesday 1 December 2009 12:12 pm
Pfizer acquires rights to Protalix's Gaucher drug
Reuters
They had closed at $9.86 Monday on the American Stock Exchange. Pfizer shares were up nearly 1 percent in trading before the bell.

and more »

More: continued here

No Comments »

No comments yet.

RSS feed for comments on this post. TrackBack URI

Leave a comment

You must be logged in to post a comment.